Plicni centrum s.r.o.
- Address
- Sidliste 1100/32, Radotin, 153 00 Prague, Czechia
Plicni centrum s.r.o. - Respiratory Disease Research Center
Plicni centrum s.r.o. is a specialized respiratory research facility dedicated to advancing the treatment of chronic airway diseases. The center demonstrates extensive expertise in conducting pivotal clinical trials for chronic obstructive pulmonary disease (COPD) and uncontrolled asthma, focusing on novel biologic therapies and their long-term safety profiles.
- Advanced COPD therapeutics including itepekimab and tezepelumab for moderate to very severe disease
- Exacerbation prevention studies in patients with uncontrolled asthma at high risk
- Long-term safety and tolerability assessments of innovative respiratory biologics
The research center specializes in evaluating next-generation biologic treatments targeting inflammatory pathways in chronic respiratory conditions. Their clinical trial portfolio includes comprehensive studies assessing the efficacy of novel agents in reducing acute COPD exacerbations in former smokers and complex asthma exacerbation events in patients who remain symptomatic despite standard inhaled corticosteroid and long-acting beta-agonist therapy. This focus on difficult-to-treat respiratory populations positions Plicni centrum as a key contributor to advancing personalized respiratory medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Plicni centrum s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Inhaled AZD8630 in Adults with Uncontrolled Asthma at Risk of Exacerbations: A Randomized, Double-Blind, Placebo-Controlled Study | AstraZeneca AB | Phase II | Not Recruiting | Jan 2025 | Feb 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Itepekimab | 2 | Unknown | 2021-03-22 | 2024-05-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.